Embremma Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Eribulin Mesylate (0.5mg/ml)
Overview Embremma Injection
Oncaspar Injection treats advanced breast cancer in adults. It's indicated for patients whose cancer has metastasized and who have undergone prior anticancer therapies. Oncaspar may be administered alone or in combination with other medications as part of a chemotherapy regimen. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits might not be immediately apparent, potentially taking weeks or months; discontinue only under your doctor's instruction. Common side effects include fatigue, alopecia, nausea, and bowel irregularity. A reduction in blood cell counts, increasing infection risk, is possible; regular blood tests monitoring blood cell levels, cardiac function, liver health, uric acid, and electrolytes are essential. Peripheral neuropathy, manifested as numbness, tingling, or paresthesia in the extremities, may occur; report persistent or bothersome symptoms to your doctor. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, particularly those for infections, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is mandatory throughout treatment.
Uses of Embremma Injection
Advanced breast cancer with distant spread
Major Benefits of Embremma Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Embremma Injection:
- Anemia (low number of red blood cells)
- Weakness
- Hair loss
- Nausea
- Constipation
- Decreased white blood cell count
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Embremma Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Embremma Injection works:
Embremma Injection is a cancer treatment that disrupts the microtubules crucial for cancer cell division and proliferation. This disruption halts the cancer cells' growth cycle, leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Embremma Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Embremma Injection during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingUNSAFE
Administering Embremma Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Embremma Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Careful consideration should be given to administering Embremma Injection to individuals with impaired renal function. Dosage modification for Embremma Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, Embremma Injection requires careful administration. Dosage modification of Embremma Injection might be necessary. Physician consultation is advised.
What if you forget to take Embremma Injection :
NA
Facts to Know About Embremma Injection
| Label | Value |
|---|---|
| Chemical Type | Halichondrin B analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Non-Taxane Microtubule Inhibitors |
3,018 People bought this recently